Clinical Trial Update: Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating retrobulbar Triamcinolone Acetonide injections for non-arteritic anterior ischemic optic neuropathy (NA-AION). The current trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-arteritic Anterior Ischemic Optic Neuropathy

Drugs mentioned

• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Second Military Medical University | Conditions: Triamcinolone Acetonide, Optic Neuropathy, Ischemic | Phase 3 | Status: UNKNOWN